These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 18172817)
21. Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion. Herraiz M; Beraza N; Solano A; Sangro B; Montoya J; Qian C; Prieto J; Bustos M Hum Gene Ther; 2003 Mar; 14(5):463-72. PubMed ID: 12691611 [TBL] [Abstract][Full Text] [Related]
22. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation]. Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912 [TBL] [Abstract][Full Text] [Related]
23. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct. Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279 [TBL] [Abstract][Full Text] [Related]
24. Improved safety of a replication-competent poxvirus-based HIV vaccine with the introduction of the HSV-TK/GCV suicide gene system. Zhang Q; Liu Z; Hou J; Wang S; Liu C; Wei M; Liu Y; Shao Y Vaccine; 2016 Jun; 34(30):3447-53. PubMed ID: 27195760 [TBL] [Abstract][Full Text] [Related]
25. Killing effect of the herpes simplex virus thymidine kinase/ganciclovir enzyme/prodrug system on human nasopharyngeal carcinoma cells. Tang Y; Li J; Zhao S; Liu J J Int Med Res; 2007; 35(4):433-41. PubMed ID: 17697519 [TBL] [Abstract][Full Text] [Related]
26. Effects of bicistronic lentiviral vector-mediated herpes simplex virus thymidine kinase/ganciclovir system on human lens epithelial cells. Yang J; Liu TJ; Lu Y Curr Eye Res; 2007 Jan; 32(1):33-42. PubMed ID: 17364733 [TBL] [Abstract][Full Text] [Related]
27. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect". Chen CY; Chang YN; Ryan P; Linscott M; McGarrity GJ; Chiang YL Hum Gene Ther; 1995 Nov; 6(11):1467-76. PubMed ID: 8573619 [TBL] [Abstract][Full Text] [Related]
28. Conservative mutations of glutamine-125 in herpes simplex virus type 1 thymidine kinase result in a ganciclovir kinase with minimal deoxypyrimidine kinase activities. Hinds TA; Compadre C; Hurlburt BK; Drake RR Biochemistry; 2000 Apr; 39(14):4105-11. PubMed ID: 10747801 [TBL] [Abstract][Full Text] [Related]
29. Mutation of herpesvirus thymidine kinase to generate ganciclovir-specific kinases for use in cancer gene therapies. Mercer KE; Ahn CE; Coke A; Compadre CM; Drake RR Protein Eng; 2002 Nov; 15(11):903-11. PubMed ID: 12538910 [TBL] [Abstract][Full Text] [Related]
30. Molecular imaging and treatment of malignant gliomas following adenoviral transfer of the herpes simplex virus-thymidine kinase gene and the somatostatin receptor subtype 2 gene. Verwijnen SM; Sillevis Smith PA; Hoeben RC; Rabelink MJ; Wiebe L; Curiel DT; Hemminki A; Krenning EP; de Jong M Cancer Biother Radiopharm; 2004 Feb; 19(1):111-20. PubMed ID: 15068619 [TBL] [Abstract][Full Text] [Related]
31. Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy. Ketola A; Määttä AM; Pasanen T; Tulimäki K; Wahlfors J Int J Mol Med; 2004 May; 13(5):705-10. PubMed ID: 15067374 [TBL] [Abstract][Full Text] [Related]
33. Increased Cytotoxicity of Herpes Simplex Virus Thymidine Kinase Expression in Human Induced Pluripotent Stem Cells. Iwasawa C; Tamura R; Sugiura Y; Suzuki S; Kuzumaki N; Narita M; Suematsu M; Nakamura M; Yoshida K; Toda M; Okano H; Miyoshi H Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769780 [TBL] [Abstract][Full Text] [Related]
34. Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression. Jacobs A; Dubrovin M; Hewett J; Sena-Esteves M; Tan CW; Slack M; Sadelain M; Breakefield XO; Tjuvajev JG Neoplasia; 1999 Jun; 1(2):154-61. PubMed ID: 10933050 [TBL] [Abstract][Full Text] [Related]
35. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model. Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258 [TBL] [Abstract][Full Text] [Related]
36. Hydroxyurea induces bystander cytotoxicity in cocultures of herpes simplex virus thymidine kinase-expressing and nonexpressing HeLa cells incubated with ganciclovir. Gentry BG; Boucher PD; Shewach DS Cancer Res; 2006 Apr; 66(7):3845-51. PubMed ID: 16585212 [TBL] [Abstract][Full Text] [Related]
37. [The mechanism of bystander effect in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy]. Zhang L; Liu T; Cui Q; Gao J Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):440-4. PubMed ID: 11869559 [TBL] [Abstract][Full Text] [Related]
38. Retrovirus-mediated transfer of the suicide gene into retinal pigment epithelial cells in vitro. Schubert CA; Kimura H; Spee C; Hinton DR; Gordon EM; Anderson WF; Ryan SJ Curr Eye Res; 1997 Jul; 16(7):656-62. PubMed ID: 9222082 [TBL] [Abstract][Full Text] [Related]
39. Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing. Black ME; Kokoris MS; Sabo P Cancer Res; 2001 Apr; 61(7):3022-6. PubMed ID: 11306482 [TBL] [Abstract][Full Text] [Related]
40. Positive selection of gene-modified cells increases the efficacy of pancreatic cancer suicide gene therapy. Martinez-Quintanilla J; Cascallo M; Gros A; Fillat C; Alemany R Mol Cancer Ther; 2009 Nov; 8(11):3098-107. PubMed ID: 19887556 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]